CA AB2326

Requires laboratories performing blood lead analysis to report additional information beginning July 1, 2023, including the National Provider Identifier of the ordering provider, the laboratory's CLIA number and NPI, and the person's race, ethnicity, and pregnancy status.

Changes the reporting timeline threshold from 10 micrograms of lead per deciliter to the most recent CDC reference level for elevated blood lead levels, with reports due within 3 working days for elevated levels and 30 calendar days for lower levels.

Waives laboratory reporting requirements for information that the health care provider cannot or will not provide when the blood lead level is below the CDC reference level.

Authorizes the State Department of Public Health to share reported information with health care providers, local health departments, environmental agencies, and for purposes of care coordination and research with appropriate oversight.

Allows information sharing with the individual tested or their parent/guardian with voluntary written consent, and with the State Department of Health Care Services to determine if Medi-Cal enrolled children are being screened for lead poisoning.